Siemens Healthcare Diagnostics has recalled 1,321 units of Atellica IM and ADVIA Centaur Erythropoietin (EPO) Assays because they provide test results that are approximately 35% lower than the international standard. These affected test kits, used to measure a hormone that stimulates red blood cell production, do not meet the reference intervals claimed in their instructions. This inaccuracy can lead to the mismanagement of patient conditions that rely on precise EPO measurements. Consumers should contact their healthcare provider or Siemens for further instructions regarding these diagnostic tools.
The 35% negative bias in test results could lead to incorrect medical diagnoses or inappropriate treatment decisions for patients with blood-related disorders. Because the assay reports lower levels of the hormone than actually present, medical professionals may misinterpret a patient's health status.
Professional consultation and instruction
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.